Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 283

Cullgen pulls in $16m

Sequoia China Capital and Highlight Capital co-led the GNI Group-backed cancer drug developer's series A round.

Apr 15, 2019

Corporate venturing deal net: 8-12 April 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Apr 12, 2019

Banks enliven EdiGene’s series B round

FujiFilm-backed genetic disorder drug developer EdiGene has secured $14.3m from investors including SBI Investment, SMBC Capital and Mizuho Capital.

Apr 12, 2019

Inozyme hardens up with $67m

Novo and Sanofi Ventures returned to reinvest in Inozyme Pharma as it looks to advance its lead mineralisation disorder drug towards the clinic.

Apr 11, 2019

ABK brings in $30m

Varian Medical Systems co-led the series B round, which will fund the development of ABK Biomedical's embolic therapies.

Apr 11, 2019

Changing attitudes – sustainability, nutrition and wellness

Perspectives on sustainability and wellbeing are changing in response to health and environmental challenges, offering an opportunity to university-linked businesses.

Apr 11, 2019

SoftBank builds Latin American investment team

SoftBank has tapped three executives to help run its $5bn Latin America-focused fund, with Paulo Passoni and Shu Nyatta to work alongside managing partner André Maciel.

Apr 10, 2019

SoYoung goes for $150m IPO

The cosmetic surgery booking and reviews platform, which counts Tencent among its investors, has filed to go public in the US.

Apr 10, 2019

Trevi Therapeutics tries for public markets

Lundbeckfonden Ventures-backed Trevi has filed for an $86.2m IPO to fund clinical trials for pruritus-focused drug treatments.

Apr 10, 2019

Taikang takes reins with healthcare fund

The insurance provider has teamed with the city of Wuhan to form a healthcare fund sized at approximately $3bn, with LPs including WeDoctor and Jointown Pharmaceutical.

Apr 9, 2019

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here